Asim Zaidi, MD
Interventional Cardiology · McHenry, ILNPI 1063641181
Payments from drug & device makers
Across 49 payments — averaging $67.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Abiomed$422
- Kerecis Limited$300
- Smith+Nephew$233
- Mimedx Group, Inc.$115
- Novo Nordisk$112
- plus $599 from 10 others
What the payments were for
- Travel & lodging$83925%
- Food & beverage$2,46675%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 19 | $1,524 |
| Abiomed | 4 | $422 |
| Kerecis Limited | 2 | $300 |
| Smith+Nephew | 2 | $233 |
| Mimedx Group, Inc. | 1 | $115 |
| Novo Nordisk | 1 | $112 |
| Boehringer Ingelheim | 1 | $110 |
| Stryker | 4 | $87 |
| Abbott | 4 | $85 |
| Angiodynamics, Inc. | 2 | $69 |
| Edwards Lifesciences | 3 | $66 |
| Misonix Inc | 1 | $60 |
| Shockwave Medical, Inc | 2 | $54 |
| Surmodics, Inc. | 1 | $40 |
| Bard Peripheral Vascular, Inc. | 1 | $16 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HawkOne$1,001
- Kerecis SurgiClose$683
- Kerecis Omega3 Marigen$387
- Impella$310
- Kerecis GraftGuide$171
- Kerecis Omega3 SurgiClose$129
- Kerecis Omega3 GraftGuide$129
- IN.PACT Admiral$128
- ALLEVYN GENTLE 10CM x 10CM (4x4)CTN 10$123
- Oasis$123
- Grafix$123
- Wegovy$112
- JARDIANCE$110
- GRAFIX PL$109
How this compares
$3,305 in reported general payments places this provider in the 25th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 115 | $172,894 |
| XareltoRivaroxaban | 58 | $69,144 |
| EntrestoSacubitril/Valsartan | 45 | $46,400 |
| Repatha SureclickEvolocumab | 16 | $17,811 |
| Atorvastatin Calcium | 386 | $4,037 |
| Metoprolol Succinate | 228 | $3,238 |
| ClopidogrelClopidogrel Bisulfate | 171 | $2,123 |
| Carvedilol | 222 | $1,995 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 24 | $1,760 |
| Losartan Potassium | 107 | $1,228 |
| Prasugrel Hcl | 15 | $1,219 |
| Rosuvastatin Calcium | 84 | $1,166 |
| Lisinopril | 126 | $1,088 |
| Metoprolol Tartrate | 115 | $1,011 |
| Amlodipine Besylate | 125 | $913 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in McHenry
- Charles DavidsonChicago$5.8M
- Ravi RamanaPalos Park$2.8M
- Mark RicciardiEvanston$2.2M
- Andrei PopElk Grove Village$1.9M
- Krishna Rocha SinghSpringfield$1.7M
- Bruce LewisMaywood$1.3M
- Justin LevisayEvanston$837K
- Atman ShahChicago$794K
- Laura DavidsonChicago$661K
- Sunil AgarwalSpringfield$609K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.